top of page
BB-11001 Troponin I/CK-MB/Myoglobin Detection Kit

BB-11001 Troponin I/CK-MB/Myoglobin Detection Kit

Product Information:

Troponin I/CK-MB/Myoglobin Detection Kit (Colloidal Gold Method)

 

Product Introduction: This product is used for the qualitative detection of cardiac troponin I (cTnI), creatine kinase-MB (CK-MB), and myoglobin (MYO) in human serum/plasma. In healthy individuals, cTnI levels in the blood are very low, but they rapidly increase and are released into the bloodstream 4-6 hours after acute myocardial infarction (AMI), remaining elevated for 6-10 days. Therefore, cTnI is a specific marker for myocardial infarction. Creatine kinase (CK) is a dimer that exists in three isoenzyme forms: BB (brain type), MM (skeletal type), and MB (hybrid type). CK-MB levels become abnormal in the blood 4-6 hours after the onset of acute myocardial infarction symptoms, peaking at 18-24 hours and returning to normal within 2-3 days, making CK-MB a traditional marker for acute myocardial infarction. Myoglobin (MYO) is released faster than other cardiac markers when muscle cells are damaged. Myoglobin serum levels exceed the normal range within 1 hour of myocardial infarction, peaking at 4-8 hours after onset. Therefore, myoglobin is an early marker of acute myocardial infarction.

Packaging Specifications: 25 tests/box

 

Application Scenarios and Downstream Customers

Application Scenarios:

  • Emergency Rooms: For rapid diagnosis of acute myocardial infarction (AMI) in patients presenting with chest pain.
  • Intensive Care Units: Continuous monitoring of cardiac biomarkers in critically ill patients.
  • Cardiology Clinics: Routine screening and diagnosis of cardiac conditions.
  • General Practice and Family Medicine: Early detection and referral for patients with suspected cardiac events.
  • Mobile Health Units: For on-site screening and rapid diagnosis during medical outreach programs and emergencies.
  • Ambulance Services: Immediate testing in pre-hospital settings for suspected cardiac events.

 

Downstream Customers:

  • Emergency Physicians and Nurses
  • Cardiologists and Cardiology Nurses
  • Primary Care Physicians and General Practitioners
  • Critical Care Physicians and ICU Staff
  • Paramedics and Ambulance Services
  • Mobile Health Unit Operators

 

Business Opportunities and Market Potential Analysis

Business Opportunities in Latin America, Arab Countries, and Africa:

  • Market Demand:

    • Latin America: High prevalence of cardiovascular diseases, combined with a growing focus on improving emergency care and diagnostics.
    • Arab Countries: Increasing investments in healthcare infrastructure and a high incidence of lifestyle-related cardiovascular conditions.
    • Africa: Growing need for accessible and rapid diagnostic tools in regions with limited healthcare infrastructure and high rates of cardiovascular diseases.
  • Market Potential:

    • Latin America: Government health initiatives and private sector growth in healthcare services.
    • Arab Countries: Expanding healthcare facilities and a strong focus on adopting advanced medical technologies.
    • Africa: Support from international health organizations and local governments aiming to improve healthcare delivery and diagnostics.

 

Resource and Condition Recommendations for Distributing This Product:

  • Resource Conditions:

    • Logistics Network: Reliable logistics system to ensure product transportation and storage at appropriate temperatures.
    • Marketing: Effective marketing strategies to raise product awareness among healthcare professionals and institutions.
    • After-Sales Service: Providing technical support and training to ensure correct product usage and maximize customer satisfaction.
  • Recommended Conditions:

    • Infrastructure: Adequate warehousing and distribution capabilities to handle storage and delivery requirements.
    • Partnerships: Establishing relationships with local hospitals, clinics, and emergency services to facilitate product adoption.
    • Sales Network: A wide customer base and sales channels to effectively reach and serve potential customers.

 

Primary Customer Targets:

  • Emergency Departments: Hospitals and clinics with emergency services requiring rapid diagnostic tools.
  • Intensive Care Units: Facilities focused on critical care and continuous patient monitoring.
  • Cardiology Clinics: Specialized clinics focusing on cardiovascular health and diagnostics.
  • General Practice and Family Medicine: Clinics providing primary care services with a focus on early detection and referral.
  • Mobile Health Units: Organizations involved in on-site healthcare delivery and emergency response.
  • Ambulance Services: Providers of pre-hospital care and emergency medical services.

 

Summary

As distributors in Latin America, Arab countries, and Africa, there are significant market opportunities and potential in distributing the Troponin I/CK-MB/Myoglobin Detection Kit (Colloidal Gold Method). With reliable logistics, effective marketing, and robust after-sales service conditions, and by establishing partnerships with local medical institutions and emergency services, this product can be successfully promoted and sold in these regions.

    握手

    1

    For Users

    If you are an end user interested in this product and want to learn more or make a purchase, please click here to register your interest. We will do our utmost to provide you with the best service.

    2

    For Agents

    If you are an agent looking to become a distributor for this product and promote it in your market, please click here to register your interest. We will provide you with detailed product information and supply chain support.

    3

    For Entrepreneurs

    If you are an entrepreneur looking to join our partnership network and participate in the distribution and market expansion of our products, please click here to register your information. We will contact you and provide partnership opportunities.

    bottom of page